Foghorn Therapeutics Inc.
FHTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,849 | -$17,936 | -$18,834 | -$19,503 |
| Dep. & Amort. | $900 | $851 | $827 | $761 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,733 | $2,692 | $2,483 |
| Change in WC | -$6,936 | -$7,720 | -$9,284 | -$8,119 |
| Other Non-Cash | $3,025 | $1,072 | $631 | -$141 |
| Operating Cash Flow | -$18,860 | -$21,000 | -$23,968 | -$24,519 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$22 | -$28 | -$479 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$4,002 | -$42,140 | -$51,124 | -$39,649 |
| Inv. Sales/Matur. | $39,575 | $75,996 | $80,553 | $62,419 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $35,573 | $33,834 | $29,401 | $22,291 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $49 | $254 | $139 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $4 |
| Financing Cash Flow | $49 | $254 | $139 | $4 |
| Forex Effect | $0 | -$292 | $0 | $0 |
| Net Chg. in Cash | $16,762 | $12,796 | $5,572 | -$2,224 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $73,822 | $61,026 | $57,162 | $59,386 |
| End Cash | $90,584 | $73,822 | $62,734 | $57,162 |
| Free Cash Flow | -$18,860 | -$21,022 | -$23,996 | -$24,998 |